{"id":"W3155125407","doi":"10.1016/s0140-6736(21)00845-x","title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Novo Nordisk","keywords":"Tolerability; Medicine; Semaglutide; Pharmacokinetics; Pharmacodynamics; Concomitant; Pharmacology; Adverse effect; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002208616,0.002175035,0.00336473,0.0003949213,0.0003717971,0.001186556,0.001016362,0.002336911,0.005042909],"category_scores_gemma":[0.001894666,0.000966607,0.002340284,0.0004429323,0.001440919,0.001349508,0.0004256565,0.00399209,0.001058631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010483,"about_ca_system_score_gemma":0.0009575115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008696881,"about_ca_topic_score_gemma":0.001640898,"domain_scores_codex":[0.9991635,0.0004114074,0.00004463517,0.000190883,0.00007423126,0.0001153527],"domain_scores_gemma":[0.9987664,0.0003639805,0.0003611203,0.0001174089,0.00005884393,0.0003323149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857293,0.002819749,0.0004413769,0.0001959596,0.000809191,0.00002523345,0.00002688888,0.0001747629,0.002449714,0.00003442238,0.0003520383,0.006941297],"study_design_scores_gemma":[0.924455,0.07168423,0.002183785,0.00001998763,0.0005407105,0.00004377877,0.0000141062,0.0003367718,0.000343252,0.00008226632,0.0002772464,0.00001885079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934948,0.003185608,0.000366442,0.0004042745,0.0002800249,0.0007072299,0.0005283979,0.00009158596,0.0009416275],"genre_scores_gemma":[0.9913926,0.001843158,0.001218606,0.0007682935,0.0004446232,0.00131329,0.0008166424,0.00003979505,0.002162974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005042909,"threshold_uncertainty_score":0.0168702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132443635642622,"score_gpt":0.3119172657700074,"score_spread":0.2905928294135812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}